Schering-Plough Licenses Intranasal Pleconaril For Common Cold
This article was originally published in The Pink Sheet Daily
Executive Summary
The product formulation from ViroPharma is in Phase II. The oral form of the drug, Sanofi's Picovir, received a "not approvable" letter in 2002 from FDA.